PAPPALARDO, FEDERICO
 Distribuzione geografica
Continente #
AS - Asia 4.321
EU - Europa 4.205
NA - Nord America 2.499
SA - Sud America 1.210
AF - Africa 71
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 12.316
Nazione #
RU - Federazione Russa 2.506
US - Stati Uniti d'America 2.388
SG - Singapore 1.661
CN - Cina 1.364
BR - Brasile 1.028
SE - Svezia 643
HK - Hong Kong 539
VN - Vietnam 411
IT - Italia 352
FR - Francia 245
DE - Germania 129
GB - Regno Unito 82
IN - India 80
AR - Argentina 71
FI - Finlandia 63
BD - Bangladesh 56
CA - Canada 53
AT - Austria 37
EC - Ecuador 36
IE - Irlanda 33
ID - Indonesia 29
IQ - Iraq 29
MX - Messico 28
PL - Polonia 25
ES - Italia 24
CO - Colombia 23
TR - Turchia 23
ZA - Sudafrica 20
PK - Pakistan 18
PY - Paraguay 18
UA - Ucraina 15
JP - Giappone 13
NL - Olanda 13
UZ - Uzbekistan 12
VE - Venezuela 12
MA - Marocco 11
SA - Arabia Saudita 11
TN - Tunisia 11
CL - Cile 10
KE - Kenya 10
OM - Oman 8
AE - Emirati Arabi Uniti 7
CH - Svizzera 7
DO - Repubblica Dominicana 7
UY - Uruguay 7
AZ - Azerbaigian 6
EG - Egitto 6
HN - Honduras 6
MD - Moldavia 6
JO - Giordania 5
KG - Kirghizistan 5
MY - Malesia 5
AU - Australia 4
DZ - Algeria 4
GT - Guatemala 4
IL - Israele 4
KW - Kuwait 4
NP - Nepal 4
PE - Perù 4
AL - Albania 3
EU - Europa 3
JM - Giamaica 3
KR - Corea 3
LT - Lituania 3
PH - Filippine 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BE - Belgio 2
CY - Cipro 2
EE - Estonia 2
HR - Croazia 2
IR - Iran 2
LB - Libano 2
MN - Mongolia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
AI - Anguilla 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CM - Camerun 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GE - Georgia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
Totale 12.305
Città #
Singapore 633
Moscow 556
Hong Kong 538
Dallas 356
San Jose 350
Ashburn 322
Shanghai 291
Hefei 235
Princeton 225
Lawrence 224
Lauterbourg 203
Beijing 143
Ho Chi Minh City 139
New York 105
Milan 101
São Paulo 89
Hanoi 86
Los Angeles 65
Helsinki 54
Nuremberg 41
Rio de Janeiro 35
Rome 34
Dublin 31
Boardman 26
Orem 25
Haiphong 23
Vienna 23
Santa Clara 22
Montreal 21
Warsaw 21
Da Nang 20
The Dalles 20
Brasília 18
Brooklyn 18
Chennai 18
Atlanta 17
Curitiba 17
Stockholm 17
Belo Horizonte 16
Guangzhou 16
Phoenix 16
Quito 15
Turin 15
Chicago 14
Columbus 14
Pune 14
Poplar 13
Porto Alegre 13
Tokyo 13
Campinas 12
Denver 12
Munich 12
Salvador 12
Frankfurt am Main 11
Houston 11
London 11
Tashkent 11
Thái Bình 11
Boston 10
Fortaleza 10
Mapello 10
Tianjin 10
Ankara 9
Dhaka 9
Guarulhos 9
Johannesburg 9
Mexico City 9
San Francisco 9
Toronto 9
Uberlândia 9
Xi'an 9
Asunción 8
Bogotá 8
Guayaquil 8
Manchester 8
Nairobi 8
Palermo 8
Santo André 8
Bauru 7
Biên Hòa 7
Bologna 7
Cesano Boscone 7
Hangzhou 7
Hải Dương 7
Lahore 7
Magé 7
Philadelphia 7
Shenzhen 7
Shijiazhuang 7
Turku 7
Wuxi 7
Baghdad 6
Calgary 6
Chengdu 6
Contagem 6
Falkenstein 6
Franca 6
Goiânia 6
Jakarta 6
Maceió 6
Totale 5.746
Nome #
470 MYOCARDIAL FIBROSIS IN ASYMPTOMATIC PATIENTS UNDERGOING SURGERY FOR MITRAL AND AORTIC VALVE REGURGITATION 194
A meta-analysis of complications and mortality of extracorporeal membrane oxygenation 140
Afterload mismatch after MitraClip insertion for functional mitral regurgitation 124
Abdominal Compartment Syndrome During Extracorporeal Membrane Oxygenation 103
A new phosphorylcholine-coated polymethylpentene oxygenator for extracorporeal membrane oxygenation: a preliminary experience 98
Optimal versus suboptimal mitral valve repair: late results in a matched cohort study 97
Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study 93
A comparison of observed versus estimated baseline creatinine for determination of RIFLE class in patients with acute kidney injury 90
Anticoagulation management in patients undergoing open heart surgery by activated clotting time and whole blood heparin concentration 89
Anticoagulation for Critically Ill Cardiac Surgery Patients: Is Primary Bivalirudin the Next Step? 87
Acute right ventricular failure post ascending aorta surgery 87
Bleeding in patients with continuous-flow left ventricular assist devices: acquired von Willebrand disease or antithrombotics? 87
An unusual cause of cardiogenic shock: tricuspid regurgitation and right ventricular perforation due to vena cava filter migration 86
An Unusual "Swinging" Biatrial Mass 83
Argatroban anticoagulation for heparin induced thrombocytopenia in patients with ventricular assist devices 83
2012 pandemic flu 83
EARLY DIAGNOSIS OF PUMP THROMBOSIS BASED ON TIME-FREQUENCY ANALYSIS OF LOG-FILES OF THE HEARTWARE HVAD VENTRICULAR ASSIST DEVICE 81
Acute heart failure management in a young patient requiring complex left main percutaneous coronary intervention, Impella 2.5 and transcatheter aortic valve implantation 81
Analysis Of The Effect Of Component Elements Of Hemodynamic Shear Stress Profiles On Shear-Mediated Platelet Activation In Cardiovascular Implantable Therapeutic Devices 80
Adjunctive therapies during veno-venous extracorporeal membrane oxygenation 80
Can we predict the thrombotic risk in patients with left ventricular assist devices? 79
Different anesthesiological management in two high risk pregnant women with heart failure undergoing emergency cesarean section 78
2019 EACTS Expert Consensus on long-term mechanical circulatory support 78
Anesthetic management of transcatheter aortic valve implantation with transaxillary approach. 77
A narrative review of the technical standards for extracorporeal life support devices (pumps and oxygenators) in Europe 76
Timing of Impella implantation and outcomes in cardiogenic shock or high-risk percutaneous coronary revascularization 74
Primary anticoagulation with bivalirudin for patients with implantable ventricular assist devices 74
Weaning from veno-venous extracorporeal membrane oxygenation: How I do it 74
ECG changes after CABG: the role of the surgical technique 73
Aortic Cannula Disruption Following Long-Term LVAD Support. 73
Venoarterial Extracorporeal Membrane Oxygenation for Acute Fulminant Myocarditis in Adult Patients: A 5-Year Multi-Institutional Experience 73
Mechanical chest compression and extracorporeal life support for out-of-hospital cardiac arrest. A 30-month observational study in the metropolitan area of Milan, Italy 70
Human protein C concentrate in pediatric septic patients 70
Performing chronic hemodialysis therapy in a patient with total artificial heart. 69
Loss of Leaflet Insertion After Percutaneous Mitral Valve Repair Requiring Left Ventricular Assist Device Implantation: Usefulness of 3D Multiplanar Reconstruction 68
Predictors of atrial fibrillation after off-pump coronary artery bypass graft surgery 67
β-Blockers to optimize peripheral oxygenation during extracorporeal membrane oxygenation: a case series 67
High Frequency Components of Hemodynamic Shear Stress Profiles are a Major Determinant of Shear-Mediated Platelet Activation in Therapeutic Blood Recirculating Devices. 67
Concomitant implantation of Impella® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock. 66
Off-pump coronary artery bypass grafting reduces postoperative neurologic complications 66
Veno-venous extracorporeal membrane oxygenation in the surgical management of post-traumatic intrathoracic tracheal transection 66
Surgical transaxillary placement of the Impella 5.0 ventricular assist device 66
Blood Purification With CytoSorb in Critically Ill Patients: Single-Center Preliminary Experience 65
Temperature management during off-pump coronary artery bypass graft surgery: a randomized clinical trial on the efficacy of a circulating water system versus a forced-air system 64
Thrombogenic Potential Of Altered Hemodynamics At The Left Ventricular Apex-LVAD Cannula Interface: A Numerical Study 64
Impella Support for Acute Myocardial Infarction complicated by Cardiogenic Shock: A Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis 64
Log Files of Continuous-Flow Left Ventricular Assist Devices Reveal Diurnal Changes of Pump Parameters Beyond Circadian Variations 64
Myocardial necrosis biomarkers after different cardiac surgical operations 63
Inflow cannula obstruction of the HeartWare left ventricular assist device: what do we really know? 63
Influence of Different Antithrombotic Regimens on Platelet-Mediated Thrombin Generation in Patients with Left Ventricular Assist Devices 63
Cardiac index assessment by the pressure recording analytic method in unstable patients with atrial fibrillation 62
The extracorporeal life support organization Maastricht treaty for nomenclature in extracorporeal life support a position paper of the extracorporeal life support organization 62
Left Ventricular Assist Device Outflow Conduit Fissuration: Endovascular Salvage 62
Timing and Strategy for Weaning From Venoarterial ECMO are Complex Issues 61
Shear-mediated platelet activation in patients implanted with continuous flow LVADs: A preliminary study utilizing the platelet activity state (PAS) assay. 61
Extracorporeal membrane oxygenation to resuscitate a 14-year-old boy after 43min drowning 61
Protein C zymogen in adults with severe sepsis or septic shock 60
Beating-heart coronary artery bypass graft surgery at San Raffaele Hospital: four years of experience 60
Peripheral VA-ECMO venous cannulation: which side for the femoral cannula? 60
COMPARATIVE ANALYSIS OF THE THROMBOGENIC POTENTIAL OF THE HEARTMATE 3 AND HEARTWARE HVAD CARDIAC PUMPS: A “NUMERICAL RATIONALE” OF CLINICAL OUTCOMES 60
Underreporting of conversion from off-pump coronary artery bypass surgery 59
Minimally invasive closed circuit versus standard extracorporeal circulation for aortic valve replacement 59
Bedside insertion of impella percutaneous ventricular assist device in patients with cardiogenic shock 58
Hemodynamic and echocardiographic effects of aortic regurgitation on femoro-femoral veno-arterial ECMO 58
Lo studio IABP-SHOCK II 58
Use of a parallel stiff wire to facilitate percutaneous Impella RP ventricular assist device positioning 58
The ELSO Maastricht Treaty for ECLS Nomenclature: abbreviations for cannulation configuration in extracorporeal life support - a position paper of the Extracorporeal Life Support Organization 58
Mid-term results of tricuspid annuloplasty with a three-dimensional remodelling ring 57
Bioline heparin-coated ECMO with bivalirudin anticoagulation in a patient with acute heparin-induced thrombocytopenia: the immune reaction appeared to continue unabated 57
Desmopressin reduces transfusion needs after surgery: a meta-analysis of randomized clinical trials 57
Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: a systematic review and meta-analysis including 8 studies and 266 patients receiving ECMO 57
Second cross-clamping after mitral valve repair for degenerative disease in contemporary practice 57
Management of cardiogenic shock in acute decompensated chronic heart failure: The ALTSHOCK phase II clinical trial 57
Platelet activation is a preoperative risk factor for the development of thromboembolic complications in patients with continuous-flow left ventricular assist device 57
Drotrecogin alpha and anticoagulants in septic patients after cardiac surgery 56
Polypoid atrial myxoma 56
First in man prolonged pressure-controlled intermittent coronary sinus occlusion to treat refractory left ventricular dysfunction and ischemia with patent epicardial coronary arteries 56
Loss of circadian rhythm in HVAD patients correlates with early diagnosis of pump thrombosis 56
International Survey on Extracorporeal Membrane Oxygenation Transport 56
Long-Term Results (<= 18 Years) of the Edge-to-Edge Mitral Valve Repair Without Annuloplasty in Degenerative Mitral Regurgitation Implications for the Percutaneous Approach 56
Recombinant activated factor VII increases stroke in cardiac surgery: a meta-analysis. 56
Coronary reactivity testing in vasospastic angina leading to cardiac arrest and coronary dissection 55
Protein C zymogen in severe sepsis: a double-blinded, placebo-controlled, randomized study 55
Clinical significance of a new Q wave after cardiac surgery 55
Ultrasound-accelerated thrombolysis and extracorporeal membrane oxygenation in a patient with massive pulmonary embolism and cardiac arrest 55
Thrombotic Risk of Rotor Speed Modulation Regimes of Contemporary Centrifugal Continuous-flow Left Ventricular Assist Devices 55
Human protein C zymogen concentrate in patients with severe sepsis and multiple organ failure after adult cardiac surgery 54
Phosphorylcholine coating may limit thrombin formation during high-risk cardiac surgery: a randomized controlled trial 54
Miniaturized cardiopulmonary bypass improves short-term outcome in cardiac surgery: a meta-analysis of randomized controlled studies 54
Long-term outcome and quality of life of patients requiring prolonged mechanical ventilation after cardiac surgery 54
Management of refractory hypoxemia during venovenous extracorporeal membrane oxygenation for ARDS 54
Levosimendan for Hemodynamic Support after Cardiac Surgery 54
Microfluidic approaches for the assessment of blood cell trauma: a focus on thrombotic risk in mechanical circulatory support devices 54
Coagulation Derangements in Patients With Refractory Cardiac Arrest Treated With Extracorporeal Cardiopulmonary Resuscitation 54
Mechanical Circulatory Support With Impella Percutaneous Ventricular Assist Device as a Bridge to Recovery in Takotsubo Syndrome Complicated by Cardiogenic Shock and Left Ventricular Outflow Tract Obstruction 54
The role of different mechanical circulatory support devices and their timing of implantation on myocardial damage and mid-term recovery in acute myocardial infarction related cardiogenic shock 54
Vasopressors and inotropes in cardiogenic shock: Is there room for "adrenaline resuscitation"? 54
Eleven Years of Venovenous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: From H1N1 to SARS-CoV-2. Experience and Perspectives of a National Referral Center 54
Prolonged refractory hypotension in cardiac surgery after institution of cardiopulmonary bypass 53
Predicting mortality risk in patients undergoing venovenous ECMO for ARDS due to influenza A (H1N1) pneumonia: the ECMOnet score 53
Totale 6.864
Categoria #
all - tutte 87.771
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.771


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 0 3 2 3
2021/2022124 2 0 2 53 10 14 12 11 5 2 3 10
2022/20231.189 508 255 103 7 5 155 50 50 42 3 3 8
2023/2024395 19 20 39 37 30 90 10 23 0 24 17 86
2024/20252.743 404 40 46 102 65 201 350 217 512 390 157 259
2025/20267.859 596 725 605 1.317 534 240 804 496 2.231 311 0 0
Totale 12.670